Literature DB >> 15650633

H-graft portacaval shunts versus TIPS: ten-year follow-up of a randomized trial with comparison to predicted survivals.

Alexander S Rosemurgy1, Mark Bloomston, Whalen C Clark, Donald P Thometz, Emmanuel E Zervos.   

Abstract

OBJECTIVE: To report long-term outcome of patients undergoing prosthetic 8-mm H-graft portacaval shunts (HGPCS) or TIPS and to compare actual with predicted survival data.
METHODS: A randomized trial comparing TIPS to HGPCS for bleeding varices began in 1993. Predicted survival was determined using MELD (Model for End-stage Liver Disease).
RESULTS: Patients undergoing TIPS (N = 66) or HGPCS (N = 66) were very similar by Child's class and MELD scores and predicted survival. After TIPS (P = 0.01) and HGPCS (P = 0.001), actual survival was superior to predicted survival. Through 24 months, actual survival after HGPCS was superior to actual survival after TIPS (P = 0.04). Compared with TIPS, survival was superior after HGPCS for patients of Child's class A and B (P = 0.07) and with MELD scores less than 13 (P = 0.04) with follow-up at 5 to 10 years. Shunt failure was less following HGPCS (P < 0.01).
CONCLUSIONS: Predicted survival data for patients undergoing TIPS or HGPCS confirms an unbiased randomization. Actual survival following TIPS or HGPCS was superior to predicted survival. Shunt failure favored HGPCS, as did survival after shunting, particularly for the first few years after shunting and for patients of Child's class A or B or with MELD scores less than 13. This trial irrefutably establishes a role for surgical shunting, particularly HGPCS.

Entities:  

Mesh:

Year:  2005        PMID: 15650633      PMCID: PMC1356908          DOI: 10.1097/01.sla.0000151884.67600.b6

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  21 in total

1.  TIPS for prevention of recurrent bleeding in patients with cirrhosis: meta-analysis of randomized clinical trials.

Authors:  A Luca; G D'Amico; R La Galla; M Midiri; A Morabito; L Pagliaro
Journal:  Radiology       Date:  1999-08       Impact factor: 11.105

2.  Determinants of mortality in patients with advanced cirrhosis after transjugular intrahepatic portosystemic shunting.

Authors:  N Chalasani; W S Clark; L G Martin; J Kamean; M A Khan; N H Patel; T D Boyer
Journal:  Gastroenterology       Date:  2000-01       Impact factor: 22.682

3.  Two-year outcome following transjugular intrahepatic portosystemic shunt for variceal bleeding: results in 90 patients.

Authors:  J M LaBerge; K A Somberg; J R Lake; R L Gordon; R K Kerlan; N L Ascher; J P Roberts; M M Simor; C A Doherty; J Hahn
Journal:  Gastroenterology       Date:  1995-04       Impact factor: 22.682

4.  The natural history of portal hypertension after transjugular intrahepatic portosystemic shunts.

Authors:  A J Sanyal; A M Freedman; V A Luketic; P P Purdum; M L Shiffman; J DeMeo; P E Cole; J Tisnado
Journal:  Gastroenterology       Date:  1997-03       Impact factor: 22.682

5.  A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts.

Authors:  M Malinchoc; P S Kamath; F D Gordon; C J Peine; J Rank; P C ter Borg
Journal:  Hepatology       Date:  2000-04       Impact factor: 17.425

6.  Differential effects on portal and effective hepatic blood flow. A comparison between transjugular intrahepatic portasystemic shunt and small-diameter H-graft portacaval shunt.

Authors:  A S Rosemurgy; E E Zervos; S E Goode; T J Black; B R Zwiebel
Journal:  Ann Surg       Date:  1997-05       Impact factor: 12.969

7.  Transjugular intrahepatic portosystemic shunt stenosis and revision: early and midterm results.

Authors:  Z J Haskal; M J Pentecost; M C Soulen; R D Shlansky-Goldberg; R A Baum; C Cope
Journal:  AJR Am J Roentgenol       Date:  1994-08       Impact factor: 3.959

8.  Transjugular intrahepatic portosystemic shunt versus distal splenorenal shunt--a comparative study.

Authors:  J S Khaitiyar; S K Luthra; N Prasad; N Ratnakar; D K Daruwala
Journal:  Hepatogastroenterology       Date:  2000 Mar-Apr

Review 9.  A model to predict survival in patients with end-stage liver disease.

Authors:  P S Kamath; R H Wiesner; M Malinchoc; W Kremers; T M Therneau; C L Kosberg; G D'Amico; E R Dickson; W R Kim
Journal:  Hepatology       Date:  2001-02       Impact factor: 17.425

10.  Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. Incidence and risk factors.

Authors:  O Riggio; M Merlli; G Pedretti; R Servi; P Meddi; R Lionetti; P Rossi; M Bezzi; F Salvatori; U Ugolotti; F Fiaccadori; L Capocaccia
Journal:  Dig Dis Sci       Date:  1996-03       Impact factor: 3.199

View more
  27 in total

1.  Laparoscopic splenectomy and azygoportal disconnection with intraoperative splenic blood salvage.

Authors:  Yuedong Wang; Yun Ji; Yangwen Zhu; Zhijie Xie; Xiaoli Zhan
Journal:  Surg Endosc       Date:  2012-01-26       Impact factor: 4.584

2.  Should stent-grafts replace bare stents for primary transjugular intrahepatic portosystemic shunts?

Authors:  Manfred Cejna
Journal:  Semin Intervent Radiol       Date:  2005-12       Impact factor: 1.513

Review 3.  [Portosystemic shunt surgery between TIPS and liver transplantation].

Authors:  G Puhl; S Gül; P Neuhaus
Journal:  Chirurg       Date:  2011-10       Impact factor: 0.955

4.  Modified laparoscopic splenectomy and azygoportal disconnection combined with cell salvage is feasible and might reduce the need for blood transfusion.

Authors:  Guo-Qing Jiang; Dou-Sheng Bai; Ping Chen; Jian-Jun Qian; Sheng-Jie Jin; Jie Yao; Xiao-Dong Wang
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

5.  Current role of surgery in portal hypertension.

Authors:  Sujoy Pal
Journal:  Indian J Surg       Date:  2011-12-13       Impact factor: 0.656

6.  Magnetic Anastomosis Rings to Create Portacaval Shunt in a Canine Model of Portal Hypertension.

Authors:  Hao-Hua Wang; Jia Ma; Shan-Pei Wang; Feng Ma; Jian-Wen Lu; Xiang-Hua Xu; Yi Lv; Xiao-Peng Yan
Journal:  J Gastrointest Surg       Date:  2018-08-21       Impact factor: 3.452

7.  Current Indications and Long-Term Outcomes of Surgical Portosystemic Shunts in Adults.

Authors:  Indrani Sen; Lavanya Yohanathan; Jussi M Kärkkäinen; David M Nagorney
Journal:  J Gastrointest Surg       Date:  2020-05-18       Impact factor: 3.452

8.  507 Warren-Zeppa distal splenorenal shunts: a 34-year experience.

Authors:  Alan S Livingstone; Leonidas G Koniaris; Eduardo A Perez; Nicholas Alvarez; Joe U Levi; Duane G Hutson
Journal:  Ann Surg       Date:  2006-06       Impact factor: 12.969

9.  Natural history of a randomized trial comparing distal spleno-renal shunt with endoscopic sclerotherapy in the prevention of variceal rebleeding: a lesson from the past.

Authors:  Roberto Santambrogio; Enrico Opocher; Mara Costa; Savino Bruno; Andrea Pisani Ceretti; Gian Paolo Spina
Journal:  World J Gastroenterol       Date:  2006-10-21       Impact factor: 5.742

10.  Survival and variceal rehemorrhage after shunting support small-diameter prosthetic H-graft portacaval shunt.

Authors:  Alexander Rosemurgy; Donald Thometz; Whalen Clark; Desiree Villadolid; Elizabeth Carey; Daphne Pinkas; Steven Rakita; Emmanuel Zervos
Journal:  J Gastrointest Surg       Date:  2007-03       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.